Multiplex Genome Editing of Immune Cells for Enhanced Functionality and Resistance to Suppressive Environment

Sat, 18 Apr 2026 01:22:55 +0000
Intellectual Property

The USPTO granted patent US12600944B2 to the Board of Regents, The University of Texas System covering methods for multiplex genome editing of immune cells, including disruption of multiple genes and insertion of chimeric antigen receptors at specific gene loci. The patent names Rafet Basar, Elizabeth Shpall, and Katy Rezvani as inventors and contains 14 claims. The filing date was November 27, 2019.